Lumiera Health Inc.
NHPHF
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 321.60K | 357.00K | 423.00K | 486.30K | 492.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 321.60K | 357.00K | 423.00K | 486.30K | 492.90K |
| Cost of Revenue | 280.20K | 295.10K | 326.60K | 373.50K | 259.00K |
| Gross Profit | 41.50K | 62.00K | 96.50K | 112.90K | 233.90K |
| SG&A Expenses | 400.60K | 573.00K | 810.00K | 1.09M | 1.21M |
| Depreciation & Amortization | 23.90K | 37.60K | 51.50K | 65.40K | 69.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 704.60K | 905.60K | 1.19M | 1.53M | 1.54M |
| Operating Income | -383.00K | -548.60K | -765.00K | -1.04M | -1.05M |
| Income Before Tax | -1.28M | -1.53M | -1.76M | -2.11M | -1.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.28 | -1.53 | -1.76 | -2.11 | -1.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.28M | -1.53M | -1.76M | -2.11M | -1.40M |
| EBIT | -383.00K | -548.60K | -765.00K | -1.04M | -1.05M |
| EBITDA | -359.10K | -511.00K | -713.50K | -977.20K | -977.20K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 679.86M | 679.86M | 679.86M | 679.86M | 543.67M |
| Average Diluted Shares Outstanding | 679.86M | 679.86M | 679.86M | 679.86M | 543.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
